Updated from 1:37 p.m. EDT
Jim Cramer doesn't buy the backlash against Amazon. He says Prime is a very powerful tool and an irresistible bargain.
Jim Cramer is bullish on Citigroup, Zoetis, Idexx Labs, AbbVie, Nucor, and Alexion.
Jiang Guorong will begin his new role in September.
The Republican plan to repeal and replace Obamacare is less popular than the bank bailouts.